A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(−)-deprenyl

mouse brain in stereotaxic coordinates

Keith B.J. Franklin, George Paxinos · 1997 · 3.1K citations

Medicine, Neurobiology, Neuroscience +9

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

H. Bernheimer, W Birkmayer, Oleh Hornykiewicz et al. · Journal of the Neurological Sciences · 1973 · 2.7K citations

Life Sciences, Neurology, Neuroscience +16

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Gabriel T. Liberatore, Vernice Jackson‐Lewis, Slobodanka Vukosavić et al. · Nature Medicine · 1999 · 1K citations

Life Sciences, Neurobiology, Neuroscience +16

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Richard E. Heikkila, Lawrence Manzino, Felicitas S. Cabbat et al. · Nature · 1984 · 1K citations

Medicine, Neuroscience, Pharmacology +14

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

Richard E. Heikkila, Arthur Hess, Roger C. Duvoisin · Science · 1984 · 1K citations

Medicine, Neuroscience, Pharmacology +17